Progentos Therapeutics
Immunomodulatory therapeutic approach that stimulates endogenous myelin repair mechanisms for multiple sclerosis
- Sector
- Biotech
- Headquarters
- WATERTOWN, MA
- Founded
- 2023
- Latest Form D
- $68.6M, May 2024
- Total capital
- $68.6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $68.6M
- 1 Form D · last May 2024
- 29 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$68.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Aleks Radovic-MorenoDirectorNamed in SEC Form D filings
- Cassidy BlundellDirectorNamed in SEC Form D filings
- Christopher LooseExecutive Officer, DirectorNamed in SEC Form D filings
- Dan JanneyDirectorNamed in SEC Form D filings
- Dmitrij HristodorovDirectorNamed in SEC Form D filings
- Marc-Olivier TurgeonDirectorNamed in SEC Form D filings
Show all 7 people
- Sanjay MagaviExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingPlatelet-derived Growth Factor Receptor (pdgfr) Alpha Inhibitors And Uses ThereofUSPTOApplication 18707909
- PendingHeterocyclic Compounds And Uses ThereofUSPTOApplication PCTUS2024028330
- PendingPlatelet-derived Growth Factor Receptor (pdgfr) Alpha Inhibitors And Uses ThereofUSPTOApplication 63501005
Show all 4 patent records
- Platelet-derived Growth Factor Receptor (pdgfr) Alpha Inhibitors And Uses ThereofApr 24, 2025 · Application 18707909Pending
- Heterocyclic Compounds And Uses ThereofApplication PCTUS2024028330Pending
- Platelet-derived Growth Factor Receptor (pdgfr) Alpha Inhibitors And Uses ThereofApplication 63501005Pending
- Heterocyclic Compounds And Uses ThereofApplication 19482548Pending
Related companies, and why
- NANOMATRONIX LLCSimilar federal contract value in Biotech · null in contracts
- Neon TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Dimension TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Arcturus BiotherapeuticsSimilar federal contract value in Biotech · null in contracts
- Crossbow TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Phoenix Animal Wellness, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .